RaySearch Laboratories AB (publ) is a leading provider of innovative software solutions for radiation therapy. The company's values are centered around excellence, innovation, and patient care. With a strong corporate philosophy, RaySearch Labs is committed to continuously improving cancer treatment by developing cutting-edge technologies. They strive to empower healthcare professionals with advanced tools that optimize treatment planning and delivery, ultimately enhancing patient outcomes. RaySearch Labs' dedication to research and development ensures that they remain at the forefront of the radiation therapy industry, delivering high-quality solutions that address the evolving challenges in cancer treatment.

RaySearch Laboratories AB (publ) is primarily present in various countries and regions around the world. Some of the key areas where the company has a strong presence include Sweden, the United States, Germany, the United Kingdom, France, China, Canada, and Japan. RaySearch Laboratories AB (publ) has established itself as a global player in the field of medical technology, specializing in advanced software solutions for radiation therapy. With its widespread presence and reach, the company continues to deliver innovative products and services to healthcare providers and professionals worldwide.

RaySearch Laboratories AB (publ) has achieved several significant milestones. Firstly, the company has developed and commercialized advanced software solutions for radiation therapy planning, including the widely acclaimed RayStation®. They have continuously improved their product portfolio to meet the evolving needs of the industry. Secondly, RaySearch Laboratories AB (publ) has expanded its global footprint by establishing a strong presence in key markets worldwide. Thirdly, the company has fostered successful collaborations with leading cancer centers and research institutions, enhancing their technological advancements and clinical expertise. Lastly, RaySearch Laboratories AB (publ) has consistently delivered strong financial results, demonstrating its solid growth trajectory in the market.

RaySearch Laboratories AB (publ) is a leading medical technology company based in Sweden. Established in 2000, RaySearch specializes in developing innovative software solutions for radiation therapy, including treatment planning systems and advanced algorithms. The company's products enable healthcare professionals to deliver precise and personalized cancer treatments, ultimately improving patient outcomes. RaySearch has a strong presence in the global market and collaborates with renowned research institutions and cancer centers worldwide. With a commitment to continuous innovation and expertise in radiation therapy, RaySearch Laboratories AB (publ) is dedicated to advancing cancer care through cutting-edge technology and industry-leading solutions.

The main competitors of RaySearch Laboratories AB (publ) in the market are Varian Medical Systems, Elekta, and Accuray Incorporated.

RaySearch Laboratories AB (publ) is primarily active in the healthcare and medical technology industries.

The business model of RaySearch Laboratories AB (publ) is focused on developing innovative software solutions for radiation therapy. RaySearch provides advanced treatment planning system (TPS) software, known as RayStation, that is used by healthcare professionals to optimize cancer treatments. The company aims to improve personalized treatment accuracy while minimizing side effects and costs. RayStation integrates with various treatment delivery systems, ensuring compatibility with a wide range of radiotherapy machines. RaySearch also offers support services and training to help healthcare institutions effectively utilize their software. This business model allows RaySearch Laboratories AB (publ) to contribute to advancements in cancer treatment through cutting-edge technology.

Az RaySearch Laboratories AB (publ) P/E mutatója 50,56.

Az RaySearch Laboratories AB (publ) KUV 4,80.

Az AlleAktien Minőségi Score RaySearch Laboratories AB (publ) esetében 3/10.

A várt RaySearch Laboratories AB (publ) forgalma 1,17 milliárd SEK.

A(z) várt RaySearch Laboratories AB (publ) nyereség 110,80 Mió. SEK.

RaySearch Laboratories AB (publ) is a leading provider of innovative software solutions for radiation therapy planning and execution. The company operates three business areas: RayStation, RayCare, and RayIntelligence. RayStation offers a powerful software solution for radiation therapy planning. The software combines advanced technologies and clinical experience to ensure precise and effective treatment planning. RayStation provides a wide range of tools and functions for planning radiation therapy procedures, including IMRT, VMAT, and arc therapy, as well as various special techniques such as stereotactic body radiation therapy and proton therapy. RayCare provides a complete software solution for managing radiation therapy centers, including resource management, patient management, and treatment management. RayCare improves processes in radiation therapy through fast, efficient, and secure management of all tasks and workflows. RayIntelligence includes software solutions for data analysis and processing in radiation therapy. Using advanced technologies such as artificial intelligence and machine learning, RayIntelligence offers a platform for creating and visualizing data models and analyses to optimize radiation therapy. RaySearch Laboratories AB (publ) offers a wide range of products and services to ensure successful and effective radiation therapy. From planning and management to data analysis and optimization, the company provides innovative solutions and support. RaySearch Laboratories AB (publ)'s customers include hospitals, medical practices, and research institutions that want to offer high-quality and personalized radiation therapy. RaySearch Laboratories AB (publ) is pursuing a long-term growth plan to solidify its position as a worldwide leader in software solutions for radiation therapy. The company invests in research and development to continually offer innovative technologies and solutions. Additionally, the company expands its reach through partnerships and alliances with other companies and institutions worldwide. In conclusion, RaySearch Laboratories AB (publ) is an innovative and dynamic company specializing in the development and improvement of software solutions for radiation therapy. Through its three business areas and wide range of products and services, the company provides comprehensive solutions for successful and effective radiation therapy.

A(z) RaySearch Laboratories AB (publ) évente alkalommal oszt ki 0 SEK összegű osztalékot.

A RaySearch Laboratories AB (publ) esetében jelenleg nem lehet kiszámítani a osztalékot, vagy a vállalat nem fizet osztalékot.

A(z) RaySearch Laboratories AB (publ) ISIN kódja: SE0000135485.

A RaySearch Laboratories AB (publ) WKN-je 905265.

Az RaySearch Laboratories AB (publ) tőzsdei rövidítése RAY B.ST.

Az elmúlt 12 hónapban a(z) RaySearch Laboratories AB (publ) osztalékot fizetett 0,25 SEK összegben. Ez körülbelül 0,15 % osztalékhozamnak felel meg. A következő 12 hóban a(z) RaySearch Laboratories AB (publ) várhatóan 0 SEK összegű osztalékot fog fizetni.

A(z) RaySearch Laboratories AB (publ) jelenlegi osztalékhozama 0,15 %.

A(z) RaySearch Laboratories AB (publ) negyedévente fizet osztalékot. Az osztalékokat a következő hónapokban osztják ki: június, június, június, június.

A RaySearch Laboratories AB (publ) az elmúlt 3 évben minden évben fizetett osztalékot.

A következő 12 hónapban 0 SEK összegű osztalékra számítanak. Ez 0 % osztalékhozamnak felel meg.

A(z) RaySearch Laboratories AB (publ) a(z) 'Egészség' szektorhoz van besorolva.

Az utolsó, RaySearch Laboratories AB (publ) által 2024. 05. 29.-án/én fizetett 1,3 SEK összegű osztalék megszerzéséhez a részvénynek az ex-nap előtti 2024. 05. 23.-nál kellett lennie a portfóliódban.

Az utolsó osztalék kifizetése 2024. 05. 29. időpontban történt.

2023 évben a RaySearch Laboratories AB (publ) 0 SEK összegű osztalékot fizetett ki.

Az RaySearch Laboratories AB (publ) osztalékait SEK fizeti ki.